{{Rsnum
|rsid=10210302
|Gene=ATG16L1
|Chromosome=2
|position=233250193
|Orientation=plus
|GMAF=0.3903
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ATG16L1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.0 | 54.0 | 31.0
| HCB | 41.6 | 44.5 | 13.9
| JPT | 59.3 | 37.2 | 3.5
| YRI | 55.1 | 36.1 | 8.8
| ASW | 54.4 | 40.4 | 5.3
| CHB | 41.6 | 44.5 | 13.9
| CHD | 57.8 | 36.7 | 5.5
| GIH | 28.7 | 47.5 | 23.8
| LWK | 63.6 | 29.1 | 7.3
| MEX | 50.0 | 36.2 | 13.8
| MKK | 51.9 | 43.6 | 4.5
| TSI | 14.7 | 59.8 | 25.5
| HapMapRevision=28
}}[[rs10210302]] has been reported in a large study to be associated with [[Crohn's disease]].

The risk allele (oriented to the dbSNP entry) is (T); the odds ratio associated with heterozygotes is 1.19 (CI 1.01-1.41), and for homozygotes, 1.85 (CI 1.56-2.21). {{PMID|17554300|OA=1
}}

{{omim
|desc=INFLAMMATORY BOWEL DISEASE 10; IBD10
|id=611081
|rsnum=10210302
}}

{{PMID Auto
|PMID=18224312
|Title=Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.
|OA=1
}}

{{PMID Auto
|PMID=18438406
|Title=Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.
|OA=1
}}

{{PMID Auto
|PMID=18533027
|Title=Worldwide population differentiation at disease-associated SNPs.
|OA=1
}}

{{PMID Auto
|PMID=20846217
|Title=Association of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot study.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10210302
|overall_frequency_n=47
|overall_frequency_d=128
|overall_frequency=0.367188
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=40
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}